(Q39834304)

English

Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

apoptotic process

0 references

0 references

murine leukemia virus

object named as

murine leukemia virus

1 reference

based on heuristic

inferred from title

6

object named as

Britta Wahren

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

author name string

Jorma Hinkula

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Lilian Walther-Jallow

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Anna Laurén

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Barbro Mäkitalo

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Monica Oberg

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Eva-Maria Fenyö

7

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Anna-Lena Spetz

8

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

0 references

publication date

21 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

6424-6431

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

DC-virus interplay: a double edged sword

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Mechanisms of MHC class I-restricted antigen processing and cross-presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Horizontal transfer of oncogenes by uptake of apoptotic bodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Canarypox virus-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor alpha secretion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Triggering of dendritic cell responses after exposure to activated, but not resting, apoptotic PBMCs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

The induction of tolerance by dendritic cells that have captured apoptotic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Uptake of Apoptotic Antigen-Coupled Cells by Lymphoid Dendritic Cells and Cross-Priming of CD8+ T Cells Produce Active Immune Unresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Induction of HIV-1-specific immunity after vaccination with apoptotic HIV-1/murine leukemia virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Perils at mucosal front lines for HIV and SIV and their hosts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Genetic immunization with multiple HIV-1 genes provides protection against HIV-1/MuLV pseudovirus challenge in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

A new cell line-based neutralization assay for primary HIV type 1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): the kinetics of evolution to neutralization resistance are related to progression rate of disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

GM-CSF in inflammation and autoimmunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Cytokine-secreting tumor cell vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

Human immunodeficiency virus pseudotypes with expanded cellular and species tropism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of in-house and commercial sample preparation and PCR amplification systems for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.06.016

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39834304&oldid=2091177101"